3-4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2h)-isoquinolinone has been researched along with Parkinson-Disease* in 1 studies
1 other study(ies) available for 3-4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2h)-isoquinolinone and Parkinson-Disease
Article | Year |
---|---|
Deficiency of Parkinson's disease-related gene Fbxo7 is associated with impaired mitochondrial metabolism by PARP activation.
The Parkinson's disease (PD)-related protein F-box only protein 7 (Fbxo7) is the substrate-recognition component of the Skp1-Cullin-F-box protein E3 ubiquitin ligase complex. We have recently shown that PD-associated mutations in Fbxo7 disrupt mitochondrial autophagy (mitophagy), suggesting a role for Fbxo7 in modulating mitochondrial homeostasis. Here we report that Fbxo7 deficiency is associated with reduced cellular NAD Topics: Adenosine Triphosphate; Cells, Cultured; Electron Transport Complex I; F-Box Proteins; Humans; Iodoacetic Acid; Isoquinolines; Membrane Potential, Mitochondrial; Mitochondria; Mitophagy; NAD; Oxygen Consumption; Parkinson Disease; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Polymorphism, Single Nucleotide; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Sodium Cyanide | 2017 |